Incyte Corp. (INCY)
95.94
-1.39
(-1.43%)
USD |
NASDAQ |
Mar 06, 16:00
95.91
-0.03
(-0.03%)
After-Hours: 20:00
Incyte SG&A Expense (TTM) : 1.376B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Insmed, Inc. | 701.17M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| Xencor, Inc. | 63.64M |